Literature DB >> 31039505

P2X4 and lysosome fusion.

Ruth D Murrell-Lagnado1, Manfred Frick2.   

Abstract

Similar to other members of the P2X receptor family, the P2X4 receptor at the plasma membrane forms a highly Ca2+ permeable, non-selective cation channel that is activated by extracellular ATP. Yet, P2X4 differs from the other subtypes, as it is predominantly localized on late endosomal, lysosomal and/or lysosome-related organelles. It is targeted there by virtue of tyrosine-based and di-leucine like trafficking motifs contained within its C-terminal and N-terminal regions respectively. The physiological role of the stable intracellular expression of P2X4 in acidic compartments has been a long-standing puzzle. Recent evidence, however, points to a dual role in the regulation of ion fluxes across lysosomal membranes to control lysosome membrane fusion and in the re-sensitization of receptors exposed to extracellular ATP.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31039505     DOI: 10.1016/j.coph.2019.03.002

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   5.547


  15 in total

Review 1.  Implication of Neuronal Versus Microglial P2X4 Receptors in Central Nervous System Disorders.

Authors:  Alexia Duveau; Eléonore Bertin; Eric Boué-Grabot
Journal:  Neurosci Bull       Date:  2020-09-05       Impact factor: 5.203

2.  Modulation of osteoblast differentiation and function by the P2X4 receptor.

Authors:  Isabel R Orriss; Bethan K Davies; Lucie E Bourne; Timothy R Arnett
Journal:  Purinergic Signal       Date:  2022-08-17       Impact factor: 3.950

Review 3.  The P2X4 Receptor: Cellular and Molecular Characteristics of a Promising Neuroinflammatory Target.

Authors:  Reece Andrew Sophocleous; Lezanne Ooi; Ronald Sluyter
Journal:  Int J Mol Sci       Date:  2022-05-20       Impact factor: 6.208

4.  Pharmacological and genetic characterisation of the canine P2X4 receptor.

Authors:  Reece A Sophocleous; Tracey Berg; Rocio K Finol-Urdaneta; Vanessa Sluyter; Shikara Keshiya; Lachlan Bell; Stephen J Curtis; Belinda L Curtis; Aine Seavers; Rachael Bartlett; Mark Dowton; Leanne Stokes; Lezanne Ooi; Ronald Sluyter
Journal:  Br J Pharmacol       Date:  2020-03-10       Impact factor: 8.739

5.  Bone phenotype of P2X4 receptor knockout mice: implication of a P2X7 receptor mutation?

Authors:  Maria Ellegaard; Tanja Hegner; Ming Ding; Lauriane Ulmann; Niklas Rye Jørgensen
Journal:  Purinergic Signal       Date:  2021-04-15       Impact factor: 3.765

Review 6.  Deciphering the Role of Endolysosomal Ca2+ Channels in Immunity.

Authors:  Abeer F Alharbi; John Parrington
Journal:  Front Immunol       Date:  2021-04-27       Impact factor: 7.561

Review 7.  Contribution of P2X4 Receptors to CNS Function and Pathophysiology.

Authors:  Alejandro Montilla; Gilda Paloma Mata; Carlos Matute; Maria Domercq
Journal:  Int J Mol Sci       Date:  2020-08-03       Impact factor: 5.923

8.  Generation and Characterization of Specific Monoclonal Antibodies and Nanobodies Directed Against the ATP-Gated Channel P2X4.

Authors:  Philine Bergmann; Elvira Garcia de Paco; Björn Rissiek; Stephan Menzel; Gudrun Dubberke; Jennifer Hua; François Rassendren; Lauriane Ulmann; Friedrich Koch-Nolte
Journal:  Front Cell Neurosci       Date:  2019-11-12       Impact factor: 5.505

9.  Deviant reporter expression and P2X4 passenger gene overexpression in the soluble EGFP BAC transgenic P2X7 reporter mouse model.

Authors:  Antonio Ramírez-Fernández; Lidia Urbina-Treviño; Giorgia Conte; Mariana Alves; Björn Rissiek; Anna Durner; Nicolas Scalbert; Jiong Zhang; Tim Magnus; Friedrich Koch-Nolte; Nikolaus Plesnila; Jan M Deussing; Tobias Engel; Robin Kopp; Annette Nicke
Journal:  Sci Rep       Date:  2020-11-16       Impact factor: 4.379

Review 10.  P2 Purinergic Signaling in the Distal Lung in Health and Disease.

Authors:  Eva Wirsching; Michael Fauler; Giorgio Fois; Manfred Frick
Journal:  Int J Mol Sci       Date:  2020-07-14       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.